Search Results - "Verweij, V"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Eplerenone does not limit ischemia–reperfusion injury in human myocardial tissue by van den Berg, T.N.A. (Daniëlle), van Swieten, H.A, Vos, J.C, Verweij, V, Wouterse, A.C, Deinum, J, Morshuis, W.J, Rongen, G.A, Riksen, N.P

    Published in International journal of cardiology (01-08-2016)
    “…Abstract Background Despite rapid reperfusion, mortality and morbidity in patients with an acute myocardial infarction remain significant. Therefore, novel…”
    Get full text
    Journal Article
  2. 2

    Sunitinib Does not Attenuate Contractile Force at Therapeutic Concentrations Following a Period of Ischemia in Isolated Human Cardiac Muscle by Thijs, A.M, Vos, A, Wouterse, A, El Messaoudi, S, van Swieten, H, Verweij, V, Herpen, C.M, van der Graaf, W.T.A, Noyez, L, Rongen, G.A

    Published in Clinical therapeutics (01-08-2014)
    “…Introduction Patients treated for cancer with the tyrosine kinase inhibitor sunitinib are at increased risk for development of heart failure, particularly…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole by Cavling Arendrup, Maiken, Cuenca-Estrella, Manuel, Lass-Flörl, Cornelia, Hope, William W.

    Published in Mycoses (01-06-2014)
    “…Summary The European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing has determined breakpoints for…”
    Get full text
    Journal Article